These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 4029886)

  • 1. Transferrin metabolism in alcoholic liver disease.
    Potter BJ; Chapman RW; Nunes RM; Sorrentino D; Sherlock S
    Hepatology; 1985; 5(5):714-21. PubMed ID: 4029886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbohydrate-deficient transferrin in serum in patients with liver diseases.
    Stibler H; Hultcrantz R
    Alcohol Clin Exp Res; 1987 Oct; 11(5):468-73. PubMed ID: 3314562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum ferritin and transferrin saturation in patients with chronic alcoholic and non-alcoholic liver diseases.
    Bell H; Skinningsrud A; Raknerud N; Try K
    J Intern Med; 1994 Sep; 236(3):315-22. PubMed ID: 8077889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum prealbumin, transferrin and immunoglobulins in fatty liver, alcoholic cirrhosis and primary biliary cirrhosis.
    Teppo AM; Maury CP
    Clin Chim Acta; 1983 Apr; 129(3):279-86. PubMed ID: 6851168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of body iron stores in the indicators of alcohol abuse and alcoholic liver injury].
    Cylwik B; Daniluk M; Chrostek L; Szmitkowski M
    Pol Merkur Lekarski; 2010 Jun; 28(168):450-3. PubMed ID: 20642102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum iron parameters in patients with alcoholic and chronic cirrhosis and hepatitis.
    Jurczyk K; Wawrzynowicz-Syczewska M; Boroń-Kaczmarska A; Sych Z
    Med Sci Monit; 2001; 7(5):962-5. PubMed ID: 11535942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Value of Serum Iron, Ferritin, and Transferrin in Chronic Alcoholic Liver Disease.
    Ribot-Hernández I; Martín-González C; Vera-Delgado V; González-Navarrete L; de Armas-González JF; Viña-Rodríguez J; Sánchez-Pérez MJ; Rodríguez-Gaspar M; González-Reimers E
    Biol Trace Elem Res; 2020 Jun; 195(2):427-435. PubMed ID: 31486016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum carbohydrate-deficient transferrin as a marker of alcohol consumption in patients with chronic liver diseases.
    Bell H; Tallaksen C; Sjåheim T; Weberg R; Raknerud N; Orjasaeter H; Try K; Haug E
    Alcohol Clin Exp Res; 1993 Apr; 17(2):246-52. PubMed ID: 8488962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbohydrate deficient transferrin (CDT) in alcoholic cirrhosis: a kinetic study.
    Henriksen JH; Grønbaek M; Møller S; Bendtsen F; Becker U
    J Hepatol; 1997 Feb; 26(2):287-92. PubMed ID: 9059948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative versus absolute carbohydrate-deficient transferrin as a marker of alcohol consumption in patients with acute alcoholic hepatitis.
    Halm U; Tannapfel A; Mössner J; Berr F
    Alcohol Clin Exp Res; 1999 Oct; 23(10):1614-8. PubMed ID: 10549992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma endotoxin concentrations in patients with alcoholic and non-alcoholic liver disease: reevaluation with an improved chromogenic assay.
    Fukui H; Brauner B; Bode JC; Bode C
    J Hepatol; 1991 Mar; 12(2):162-9. PubMed ID: 2050995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accumulation of glycoprotein in the Golgi apparatus of hepatocytes in alcoholic liver injuries.
    Matsuda Y; Takada A; Takase S; Sato H
    Am J Gastroenterol; 1991 Jul; 86(7):854-60. PubMed ID: 2058628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of rat models to mimic alterations in iron homeostasis during human alcohol abuse and cirrhosis.
    Gentry-Nielsen MJ; Preheim LC; Lyman KN; McDonough KH; Potter BJ
    Alcohol; 2001 Feb; 23(2):71-81. PubMed ID: 11331104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased endotoxin-binding capacity of whole blood in patients with alcoholic liver disease.
    Schäfer C; Greiner B; Landig J; Feil E; Schütz ET; Bode JC; Bode C
    J Hepatol; 1997 Mar; 26(3):567-73. PubMed ID: 9075664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein AI and alcoholic liver disease.
    Poynard T; Abella A; Pignon JP; Naveau S; Leluc R; Chaput JC
    Hepatology; 1986; 6(6):1391-5. PubMed ID: 3098667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of ethanol challenge on serum glycoproteins in alcoholic and non-alcoholic liver disease.
    Cobden I; Matthewson K; Carr WP; Dick WC; Record CO
    Alcohol Alcohol; 1987; 22(3):257-63. PubMed ID: 2441717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum ubiquitin levels in patients with alcoholic liver disease.
    Takagi M; Yamauchi M; Toda G; Takada K; Hirakawa T; Ohkawa K
    Alcohol Clin Exp Res; 1999 Apr; 23(4 Suppl):76S-80S. PubMed ID: 10235284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Carbohydrate-deficient transferrin and liver diseases. Study of 94 patients].
    Ouyahya F; Bacq Y; Schellenberg F; Metman EH; Weill J
    Gastroenterol Clin Biol; 1995; 19(8-9):698-702. PubMed ID: 8522119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver hepcidin mRNA expression is inappropriately low in alcoholic patients compared with healthy controls.
    Costa-Matos L; Batista P; Monteiro N; Simões M; Egas C; Pereira J; Pinho H; Santos N; Ribeiro J; Cipriano MA; Henriques P; Girão F; Rodrigues A; Carvalho A
    Eur J Gastroenterol Hepatol; 2012 Oct; 24(10):1158-65. PubMed ID: 22732356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study of the microheterogeneity of transferrin in cirrhotic patients.
    Poupon RE; Papoz L; Sarmini H; Elinck R
    Clin Chim Acta; 1985 Oct; 151(3):245-51. PubMed ID: 4053385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.